## **Core Concept**
Clinical trials are divided into four phases: Phase I, II, III, and IV. These phases involve testing new drugs or treatments on human subjects, with the primary goal of evaluating their safety, efficacy, and optimal dosage. Healthy normal human volunteers typically participate in early phases.

## **Why the Correct Answer is Right**
Phase I trials are the first stage of testing in human subjects and primarily focus on assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of a drug. These trials are conducted with a small group of healthy volunteers, usually between 20 to 80 participants. The main purpose here is to determine a safe dosage range and identify side effects. Therefore, healthy normal human volunteers participate in **Phase I** clinical trials.

## **Why Each Wrong Option is Incorrect**
- **Option A (Phase II):** This phase involves patients with the condition the drug aims to treat, not healthy volunteers. The goal is to obtain preliminary data on whether the drug works in people who have a certain disease or condition.
- **Option C (Phase III):** Conducted with larger groups of patients, Phase III trials confirm efficacy, monitor side effects, compare the drug to commonly used treatments, and collect information that will allow the experimental drug to be used safely. Patients, not healthy volunteers, participate in this phase.
- **Option D (Phase IV):** These are post-marketing surveillance trials, involving patients who are already using the drug. The aim is to monitor the drug's effect in a general population.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Phase I trials** are where the initial assessment of safety and pharmacokinetics is done, often involving **healthy volunteers**. This phase is critical for determining the safety profile of a new drug.

## **Correct Answer:** . Phase I